Physiological assessment of muscle strength in vitro after direct injection of doxorubicin into rabbit sternocleidomastoid muscle

Authors

  • Jon H. Falkenberg MS,

    1. Department of Physiology, University of Minnesota, Minneapolis, Minnesota, USA
    Search for more papers by this author
  • Paul A. Iaizzo PhD,

    1. Department of Anesthesiology, University of Minnesota, Minneapolis, Minnesota, USA
    2. Department of Physiology, University of Minnesota, Minneapolis, Minnesota, USA
    Search for more papers by this author
  • Linda K. McLoon PhD

    Corresponding author
    1. Department of Ophthalmology, University of Minnesota, Minneapolis, Minnesota, USA
    • Department of Ophthalmology, University of Minnesota, Room 374 Lions Research Building, 2001 6th Street SE, Minneapolis, MN 55455
    Search for more papers by this author

Abstract

Doxorubicin chemomyectomy is a potent method for the permanent removal of a muscle or group of muscles after direct local injection, and has been used successfully to treat blepharospasm and hemifacial spasm patients. The efficacy of doxorubicin chemomyectomy on reducing muscle strength after direct injection of doxorubicin into rabbit sternocleidomastoid muscle was tested. One- and 6-month postinjection force assessment was performed in vitro to measure alterations in peak twitch and tetanic force generation, as well as fatigue responses for the treated muscles compared to control. There were significant reductions of both twitch and tetanic peak amplitudes in the doxorubicin-treated muscles. One month after treatment, the decreases in force were greater after 2 mg doxorubicin injections than after 1 mg doxorubicin. While there was a significant reduction in force generation after doxorubicin treatment, fatigue resistances for the doxorubicin-treated muscles were increased compared to the controls. There were significant reductions in muscle mass after doxorubicin treatment, and by 6 months, the myosin heavy chain isoform distribution was similar to normal sternocleidomastoid, except for an increase in slow myosin-positive fibers. Doxorubicin chemomyectomy resulted in a significant reduction in functional force generation in the treated sternocleidomastoid muscles. These findings suggest a potential clinical use of doxorubicin chemomyectomy to treat cervical dystonia patients. © 2001 Movement Disorder Society.

Ancillary